On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

Listen Live Now » 1440 AM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
49° Feels Like: 46°
Wind: ENE 7 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Partly Cloudy 54°

Tonight

Partly Cloudy 44°

Tomorrow

Partly Cloudy 66°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Shire says new dry-eye drug fails to meet trial goal

LONDON (Reuters) - Drugmaker Shire said on Wednesday that its Lifitegrast treatment for adults with dry eye disease failed to meet one of two goals in a late-stage trial, the same result it saw in trial results in December. [ID:nL5N0JL1A5]

The drug met one goal for patient-reported symptoms of dry eye compared with placebo, the company said, but did not meet the second target based on signs of corneal staining.

Lifitegrast - a potential competitor for Allergan's Restasis, which is expected to have sales of around $900 million this year - is viewed as a key new product for Shire as it seeks to diversify its product line-up.

(Reporting by Paul Sandle; Editing by Brenda Goh)

Comments